[Parasitological and immunological progress control during and after chemotherapy of canine leishmaniasis]

Schweiz Arch Tierheilkd. 1992;134(2):85-93.
[Article in German]

Abstract

Promastigote Leishmania-organisms were diagnostically cultivated in vitro from popliteal lymph node aspirates obtained from 32 of in total 36 dogs returning from endemic areas. Isoenzyme analysis (glucosephosphate-isomerase (GPI), phosphoglucomutase (PGM) and glutamate-oxaloacetate-transaminase (GOT) resulted in the identification of Leishmania infantum (syn. Leishmania (L.) infantum) for all 18 isolates investigated. Parasites were still able to be cultivated in vitro in 79% of 28 biopsies (from 15 dogs) even following chemotherapy by Glucantime, independent of the time of sampling and the course of disease after treatment. Dogs with a progressive form of disease (despite chemotherapy) showed only a minor or no reduction (between 0 and 4.8%) of the relative antibody concentration (determined by ELISA), whereas regressive forms of disease (without recurrences observed in the period of 10 to 37 months after therapy) demonstrated a marked reduction of the relative antibody concentration (between 6.7 and 16.2%) within the first 5 to 8 months; thereafter the decrease diminished and changed to a persistent low relative antibody concentration.

MeSH terms

  • Animals
  • Antibodies, Protozoan / blood
  • Antiprotozoal Agents / therapeutic use*
  • Dog Diseases / drug therapy*
  • Dogs
  • Leishmania donovani / immunology
  • Leishmania donovani / isolation & purification*
  • Leishmaniasis, Visceral / drug therapy
  • Leishmaniasis, Visceral / veterinary*
  • Lymph Nodes / parasitology
  • Meglumine / therapeutic use*
  • Meglumine Antimoniate
  • Organometallic Compounds / therapeutic use*

Substances

  • Antibodies, Protozoan
  • Antiprotozoal Agents
  • Organometallic Compounds
  • Meglumine
  • Meglumine Antimoniate